Troy N Trevino, Avital B Fogel, Guliz Otkiran, Seshadri B Niladhuri, Mark A Sanborn, Jacob Class, Ali A Almousawi, Benoit Vanhollebeke, Leon M Tai, Jalees Rehman, Justin M Richner, Sarah E Lutz
Respiratory infection with SARS-CoV-2 causes systemic vascular inflammation and cognitive impairment. We sought to identify the underlying mechanisms mediating cerebrovascular dysfunction and inflammation following mild respiratory SARS-CoV-2 infection. To this end, we performed unbiased transcriptional analysis to identify brain endothelial cell signalling pathways dysregulated by mouse adapted SARS-CoV-2 MA10 in aged immunocompetent C57Bl/6 mice in vivo. This analysis revealed significant suppression of Wnt/β-catenin signalling, a critical regulator of blood-brain barrier (BBB) integrity. We therefore hypothesized that enhancing cerebrovascular Wnt/β-catenin activity would offer protection against BBB permeability, neuroinflammation, and neurological signs in acute infection. Indeed, we found that delivery of cerebrovascular-targeted, engineered Wnt7a ligands protected BBB integrity, reduced T-cell infiltration of the brain, and reduced microglial activation in SARS-CoV-2 infection. Importantly, this strategy also mitigated SARS-CoV-2 induced deficits in the novel object recognition assay for learning and memory and the pole descent task for bradykinesia. These observations suggest that enhancement of Wnt/β-catenin signalling or its downstream effectors could be potential interventional strategies for restoring cognitive health following viral infections.
Front Mol Neurosci. 2022 May 09;15:895429
[PMID:
35615065]
Cell. 2022 Jul 7;185(14):2452-2468.e16
[PMID:
35768006]
Sci Transl Med. 2022 Sep 28;14(664):eabq3059
[PMID:
35857629]
Brain. 2022 Nov 21;145(11):4097-4107
[PMID:
36065116]
Lancet Neurol. 2020 Nov;19(11):919-929
[PMID:
33031735]
N Engl J Med. 2021 Feb 4;384(5):481-483
[PMID:
33378608]
EBioMedicine. 2022 May;79:103999
[PMID:
35439679]
Brain. 2022 Dec 19;145(12):4193-4201
[PMID:
36004663]
Nat Neurosci. 2019 Aug;22(8):1276-1288
[PMID:
31235930]
Prog Neurobiol. 2021 Apr;199:101937
[PMID:
33383106]
Acta Neuropathol. 2023 Nov;146(5):771-775
[PMID:
37624381]
Cell. 2020 Nov 12;183(4):1070-1085.e12
[PMID:
33031744]
Immunity. 2021 Jul 13;54(7):1594-1610.e11
[PMID:
34174183]
Nat Med. 2017 Apr;23(4):450-460
[PMID:
28288111]
Fluids Barriers CNS. 2022 Aug 18;19(1):63
[PMID:
35982454]
J Cereb Blood Flow Metab. 2021 Jun;41(6):1179-1192
[PMID:
33530831]
Front Immunol. 2022 Dec 15;13:1070379
[PMID:
36591311]
Ann Clin Transl Neurol. 2020 Nov;7(11):2221-2230
[PMID:
33016619]
Science. 2022 Jan 21;375(6578):267-269
[PMID:
35050660]
Brain. 2022 Jul 29;145(7):2555-2568
[PMID:
35788639]
Science. 2022 Feb 18;375(6582):eabm4459
[PMID:
35175798]
Viruses. 2022 Dec 30;15(1):
[PMID:
36680154]
Nat Neurosci. 2021 Nov;24(11):1522-1533
[PMID:
34675436]
Stem Cell Reports. 2022 Feb 8;17(2):307-320
[PMID:
35063125]
Nat Neurosci. 2024 Mar;27(3):421-432
[PMID:
38388736]
Brain. 2021 Oct 22;144(9):2696-2708
[PMID:
33856027]
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1168-E1177
[PMID:
28137846]
Nat Immunol. 2023 Jul;24(7):1173-1187
[PMID:
37291385]
Acta Neuropathol Commun. 2022 Dec 17;10(1):186
[PMID:
36528671]
Lancet Psychiatry. 2022 Oct;9(10):815-827
[PMID:
35987197]